{"title":"New Standard TKI Initial Therapy for NSCLC With Uncommon EGFR Mutations","authors":"Peter M. Goodwin","doi":"10.1097/01.cot.0001007152.05233.04","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":510505,"journal":{"name":"Oncology Times","volume":"15 7","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology Times","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/01.cot.0001007152.05233.04","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
IF 5.3 2区 医学Lung CancerPub Date : 2020-01-01DOI: 10.1016/j.lungcan.2019.11.018
Shuo Yang , Shiqi Mao , Xuefei Li , Chao Zhao , Qian Liu , Xiaofei Yu , Yan Wang , Yiwei Liu , Yingying Pan , Chunyan Wang , Guanghui Gao , Wei Li , Anwen Xiong , Bin Chen , Hui Sun , Yayi He , Fengying Wu , Xiaoxia Chen , Chunxia Su , Shengxiang Ren , Caicun Zhou
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
